SAB Biotherapeutics, Inc. Common Stock
$3.29
▼ 0.06
(-1.79%)
Volume: 2,445,828
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
22
- 21d momentum -15.2%
- MA aligned bearish
- RSI 36
🎯
Pullback
62
- Near lower Bollinger band
- -6.8% vs 20MA
💎
Value
58
- -36% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)36.2
MACD-0.017
MA trendBearish
ATR4.80%
21d mom.-15.2%
63d mom.-13.4%
vs 20MA-6.8%
RVOL(20)5.92×
52w low · 2
52w high · 5
-36.1% from 52-week high
20d support 3
· resistance 4
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$305M
PER—
PBR1.42
PSR—
EPS$-0.43
ROE-18.1%
ROA-16.3%
Dividend yield0.00%
Debt/Equity0.01
EV/EBITDA-4.36
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -6.27% | -15.21% | -13.42% | -14.10% | +52.31% | -12.73% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -11.56%, daily vol 2.33%. SAB Biotherapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.